DatasetName,ERCC6L_C(984) ERCC6L_S(1000) ERCC6L_S(1004) ERCC6L_S(1025) ERCC6L_S(1028) ERCC6L_S(1036) ERCC6L_S(1069) ERCC6L_S(1076) ERCC6L_S(1077) ERCC6L_S(1081) ERCC6L_S(1082) ERCC6L_S(1086) ERCC6L_S(1098) ERCC6L_S(1117) ERCC6L_S(1134) ERCC6L_S(1135) ERCC6L_S(1173) ERCC6L_S(1181) ERCC6L_S(1188) ERCC6L_S(1242) ERCC6L_S(1337) ERCC6L_S(14) ERCC6L_S(399) ERCC6L_S(712) ERCC6L_S(738) ERCC6L_S(739) ERCC6L_S(755) ERCC6L_S(774) ERCC6L_S(807) ERCC6L_S(810) ERCC6L_S(820) ERCC6L_S(825) ERCC6L_S(828) ERCC6L_S(829) ERCC6L_S(832) ERCC6L_S(835) ERCC6L_S(864) ERCC6L_S(872) ERCC6L_S(905) ERCC6L_S(946) ERCC6L_S(951) ERCC6L_S(968) ERCC6L_S(969) ERCC6L_S(971) ERCC6L_S(980) ERCC6L_S(982) ERCC6L_S(984) ERCC6L_S(988) ERCC6L_S(995) ERCC6L_T(1063) ERCC6L_T(763) ERCC6L_T(797) ERCC6L_T(805) ERCC6L_T(813) ERCC6L_T(826) ERCC6L_T(997) ERCC6L_Y(696) ERCC6L_Y(951),ERCC6L_Y(867)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5115752575911501,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5201982366592245,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.519546140027689,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5252535557889829,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5189497030885106,
HS2024_6_B_T3,0.5239935419654551,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.5224147940883178,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5293808266300042,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5169514167343765,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5301620548722368,
FSO2013_Ratio M/L normalized Rep1___1,0.5292723328279292,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5248627018802764,
WZ2023_Pu_010_30min,0.5144654321791675,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5269962859711383,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5343001343742334,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5111826083077686,
AH2018_SILAC_MR_2_N,0.5264869265187715,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5191410312955325,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.5230470969117186,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5222421586376109,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.515054867212823,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5186818433765332,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5227442383360523,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.5187516724436193,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5168231173215023,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5175396914548148,
AH2018_SILAC_MR_2_X,0.5258092762221506,
HS2024_4_PD_T2,0.5283447836451136,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5237372192053378,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.5204070913778509,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5239812789349423,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5226377442999481,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5216490179308587,
HS2024_7_PD_T2,0.5253194536153254,
FSO2013_Ratio H/L normalized Rep1___1,0.525277275788908,
AH2018_LFQ_1_C,0.5273118728144033,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.519699189384994,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5217977617273986,
CK2022_11 40-1,0.516911389552523,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5204281814217511,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5188279661355181,
FSO2013_Ratio H/L normalized Rep2,0.521073384085958,
WZ2023_Pu_005_20min,0.5184089607298749,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.523333381890813,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5155904944591314,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5303305796264782,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5139005227352915,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5195936249636282,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,0.5201096689319198,
RCJD2014_20min_mean,0.524222426994804,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5235509875723511,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5209723018841101,
CK2022_1 200-1,0.5246321475777755,
PG2020_Intensity Mock_10h_D,0.5178627500910187,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.515841415778487,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5286703361601783,
RCJD2014_5min_1,0.5204247253686705,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.5194057489962024,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5202432530378546,
PG2020_Intensity 2h_C,0.5197033085685256,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5170015168206059,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5158335508016902,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.5224732439465655,
HS2024_5_PD_T1,0.5249050908007232,
AH2018_LFQ_M_2_C,0.5276762983131748,
CK2022_3 40-1,0.5179565398292646,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5262193996854215,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.5225988522398786,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.521119735900235,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.511414701456322,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5222440956582803,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.526173037545614,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5237637854102649,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5126063367350763,
HS2024_8_I_T3,0.5305312712128238,
CF2017_EOC 3,0.520820347069392,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5171605401369859,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5177501971609448,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5178530294009026,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.519184349869438,
KS2014_Intensity N3,0.5423916984512316,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5261837042363166,
FSO2013_Ratio H/M normalized Rep2,0.5220528426317936,
RAM2015_Log2 A,0.5309384210823967,
HS2024_8_PD_T1,0.5220463106814489,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5215954982161959,
KS2014_Intensity E15_2,0.51410272492429,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5186055883784471,
HS2024_7_I_T1,0.5237255921794407,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5197084617669071,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5210167714400581,
AH2018_SILAC_M_3_X,0.5224325158128861,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5189204405558088,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5234466799441087,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5253946391550769,
HS2024_6_B_N1,0.5246898702898606,
KBE2022_Log2_Ex_27_T,0.5217675898664504,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5225792728086074,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5167018448326921,
FSO2013_Ratio M/L normalized Rep2,0.5234353551595529,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5251073131706667,
SR2019_HCC1954_Biol_repl_2,0.5203091197850871,
CK2022_14 40-1,0.5182489932536323,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5176847060679349,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5256582046729795,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5461829129561342,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5213105425661226,
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5262897793508936,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.520086725525831,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5280612185098705,
JW2021_After_3,,
GF2025_P8_Sph,0.5156326561076048,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5206316166985052,
CK2022_11 200-1,0.5194998268198628,
CK2022_12 200-1,0.5198763477105122,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5213552592819811,
WZ2023_Su_010_20min,0.516206865122978,
AH2018_TMTMS2_2_N,0.536227907503654,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5214599982469434,
KS2014_Intensity N4,0.544942919634627,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5216796251504939,
CK2022_14 200-1,0.5228130903960353,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5198802510202022,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5133605236604172,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,0.5218360228086286,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5207098322470612,
GF2025_P1_Adh,0.5236945944204485,
GF2025_P1_Sph,0.5171031673957857,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.5157604695286008,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5247948585258829,
CF2017_EOC 1,0.5174032387529801,
CK2022_3 200-1,0.5243777855325457,
AH2018_LFQ_IT_3_C,0.5213461228689366,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5229744912581976,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5207268806153024,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5257624978055655,
HS2024_5_B_T1,0.5241235037180138,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5288427494602722,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5176047459192655,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5246361507187438,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5196789104157366,
AR2021_ALG 1 μM,0.5308493209143409,
HS2024_4_B_T1,0.5283013969936949,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5232955351762595,
CR2017_Ratio Replicate 3.2,0.5176923491395453,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5174506374030611,
CK2022_9 16-1,0.5173707155552986,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5230618489766518,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5078924450358812,
CK2022_16 16-1,0.5197980029476261,
FS2019_db/db3,,
CK2022_15 40-1,0.5180595559811865,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5181192802279362,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5203930784825246,
HS2024_5_PD_T3,0.5237019479647466,
AH2018_TMTMS3_3_X,0.5232302790778934,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.5286154631436866,
KBE2022_Log2_Ex_27_U,0.5218951357338135,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5265386482116995,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5131634084348315,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5177588760857511,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5239174523556219,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5190127828459492,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5229821930727538,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.516904748909559,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5227094201446381,
HH2022_Reporter intensity 6,0.5237577461609232,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.5203886892107744,
AH2018_TMTMS2_3_X,0.5352443865208155,
GF2025_P3_Adh,0.5229159991605319,
SR2019_JIMT1_Biol_repl_2,0.5199448861062416,
AH2018_TMTMS2_1_C,0.5355426386492961,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5228971919194917,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5234205643869123,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5232873295471039,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5248652316301867,
AH2018_LFQ_1_X,0.5217808385332615,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5204070296001697,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5504059067686561,
HH2022_Reporter intensity 1,0.5197988543108845,
HH2022_Reporter intensity 2,0.5201312884487428,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,0.5195046347906547,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5161777763409351,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5192111887764753,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5205987913459605,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5141757458136145,
AR2021_KD 72h,0.5218939508245909,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5216845201965838,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5213871897656319,
KBE2022_Log2_Ex_9_U,0.5216951397837061,
AH2018_SILAC_M_3_N,0.5213316507168987,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5127880584473256,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5169917755141982,
PG2020_Intensity 10h_A,0.5148544783904286,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5223365217532095,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5267271534332523,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5182378289691518,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.505322928726051,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5076628564615424,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5239228475545206,
CK2022_7 200-1,0.5229536512307967,
CK2022_5 200-1,0.5225962740342674,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5211820519311644,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5238372208350011,
AH2018_SILAC_MR_1_X,0.5286515807279039,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.5224111134645294,
RM2024_Intensity D4-1,0.5191847354834154,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,0.5223371259627542,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5261938453049775,
CK2022_4 16-1,0.520440897164135,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5272773379324855,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5199839288531647,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5022155612326791,
FSO2013_Ratio H/L normalized Rep3,0.5168334623087568,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5213627842379882,
KBE2022_Log2_Ex_9_T,0.5215273875493946,
AH2018_SILAC_IT_2_N,0.5216401449341642,
AH2018_SILAC_IT_1_X,0.5227799074523877,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5211780504867939,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5177418122776861,
WZ2023_Pe_025_20min,0.5261283056495332,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.525069575537269,
HS2024_4_I_N2,0.5230309837148951,
AH2018_TMTMS2_3_N,0.5358245494694461,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5315677152716695,
WZ2023_Su_005_30min,0.5181637136189816,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.5217285269988015,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5264088755461739,
WZ2023_Su_025_10min,0.5209424550089703,
AH2018_LFQ_IT_4_X,0.5226233985559543,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5197616922281477,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5125378541091119,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5183500218972277,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5393474848938651,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5111797292303917,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.513098207651739,
RN2012_L10,,
PG2020_Intensity 4h_C,0.511541343238494,
EP2017_Mitotic R#3 normalized log2 ratio,0.524983347008798,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5225271629055994,
HS2024_4_B_T3,0.528590549075827,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5206037362722588,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5214450084003176,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5232523614076056,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5229036469642981,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5308981517706646,
GF2025_P9_Sph,0.5161379996386011,
CK2022_6 200-1,0.5229547944202,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5234910649521761,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.5209579462097944,
HS2024_4_I_T2,0.5286431629646595,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5211648874097179,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.5223044141682747,
HS2024_3_B_T3,0.5239883230156919,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5166313120708643,
EP2017_Untreated R#3 normalized log2 ratio,0.5127071186527475,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5228545253503697,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5174572523582964,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5214353253959004,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5213762249847762,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5167633801764059,
KBE2022_Log2_Ex_29_T,0.5217768038554523,
HS2024_7_I_T2,0.5206040884079626,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5224271354501263,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5265281537652703,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.5115289102312214,
ZCP2016_Ratio H/L Rep 1,0.5240150012953234,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,0.5134050362012148,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5198088230736626,
HS2024_8_PD_T2,0.5199157025592807,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5244984974855949,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.516088259765213,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5206433330050191,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5233545567270556,
HS2024_3_PD_T3,0.5258421809996844,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5193194118446294,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5270793549970041,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.5204702587445269,
RAM2015_Log2 B,0.5271547596309856,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.518511003033562,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5315326657553545,
PG2020_Intensity Mock_10h_B,0.5197216466604411,
WZ2023_Su_025_30min,0.5194318317584324,
AH2018_LFQ_4_N,0.5266027056998805,
CR2017_Ratio Replicate 1.2,0.5253674015776633,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5184952593013427,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5234565007218092,
AH2018_SILAC_M_1_X,0.5260856139818937,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5225356191442835,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5367297963073372,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5199024460381989,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5228413070683875,
RM2024_Intensity D0-1,0.5166875791852464,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5256122290066189,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.530604590997957,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5272420355515431,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.51432051094729,
AH2018_LFQ_2_X,0.5264615790297797,
PG2020_Intensity 2h_B,0.5167356461121632,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5153432781740267,
GF2025_P3_Sph,0.5179040545314159,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5252440918526207,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5214138733742165,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5154735516988985,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5270152142076158,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.5160713638115891,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.5179225712005736,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.514244259888665,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5265527367444512,
WZ2023_Su_025_20min,0.5191462503207196,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.5221027236438643,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5244337906471472,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5180792838080486,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.5167260086866826,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5223293005070555,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5237323590990233,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5205515364455442,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5297339984684538,
AH2018_LFQ_M_4_C,0.5273342033342093,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.518191241387096,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.5212736010110638,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5237096884354462,
HS2024_8_PD_T3,0.5220296089462542,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5198310882405065,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5186138638950927,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5168845038988479,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5274025627313116,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5384646942833459,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5212420773471129,
HS2024_8_I_N2,0.5188969324120841,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5261463073395294,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.5206725311685495,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5238262741155372,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5213096886400209,
LY2019_P2-,0.5263997202919961,
AH2018_LFQ_IT_1_X,0.5256923268575862,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5229571847265884,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5256677864207514,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5228776350851142,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5180938123166416,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5212852716296166,
HS2024_5_B_T2,0.5261988943588658,
HS2024_6_I_T1,0.5179294975824176,
HS2024_5_B_T3,0.5466674390971713,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5220881948464602,
AH2018_TMTMS3_3_N,0.5208054634743078,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.526501781203135,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5267024300424452,
KBE2022_Log2_Ex_36_T,0.522195522487092,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5175414837390825,
KS2014_Intensity C2,0.5183400915626541,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5195739058232919,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5196695116892764,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5200420917288621,
RBK2021_1332T Late,,
LY2019_P1-,0.5207928477204191,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5160962923999864,
HS2024_3_I_T3,0.521522227785235,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5125266293720995,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5137101171599211,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5184755417641844,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.526925921994617,
KS2014_Intensity N1,0.5466271838138377,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5246696285023973,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5216692135077811,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5200080668299542,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5279913303992757,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,0.5216588062986803,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.522177853359755,
HS2024_5_I_N1,0.5199025973115347,
HS2024_6_I_N1,0.52196857629827,
AR2021_KD 48h,0.5251634616203485,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5452837505663051,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.5209624283152097,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.520142853329203,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5239700129101066,
KBE2022_Log2_Ex_29_U,0.5219119731689074,
HS2024_7_B_T1,0.5155638363819609,
AH2018_LFQ_M_2_X,0.526948076199839,
AH2018_LFQ_IT_4_N,0.5222361515934052,
CK2022_15 200-1,0.5230543502517487,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5204756121590118,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5241624917211064,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.518857550977601,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5169820777139243,
HS2024_8_B_T3,0.5052761076805892,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.523307451809866,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.526010732930164,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.520246437392951,
KS2014_Intensity C1,0.5189500825445552,
FSO2013_Ratio H/M normalized Rep3___1,0.5143034423096791,
AH2018_SILAC_M_3_C,0.5223117261391617,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5223413114622444,
AH2018_SILAC_M_2_X,0.5204262877754665,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5206956638202542,
PG2020_Intensity 6h_C,0.5197917402895174,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5248848473336906,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5377276329705402,
CK2022_15 16-1,0.5196046434880592,
CK2022_3 16-1,0.5206577638351503,
LY2019_P4-,0.5245605899289167,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5244233339764216,
GF2025_P8_Adh,0.5276225886223755,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.5216438518375159,
GF2025_P5_Sph,0.5177723583272477,
CK2022_10 16-1,0.5181865532743938,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,0.5222118856885803,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5320340045544539,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5213482386376239,
AR2021_L41 10 μM,0.527266283908174,
CF2017_EOC 2,0.5204494753108215,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5261731178788396,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5199627757966202,
CK2022_6 16-1,0.5192413371267477,
ZX2022_CB treated Replicate 1,0.5167793684459209,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5201930752389482,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5332348496259386,
AR2021_L41 1 μM,0.5305363439064273,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5353213825925394,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.519005275275419,
KS2014_Intensity C4,0.5116068728955175,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5221061753694146,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5199523505242284,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5108615941380967,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5284598248805658,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5284163035931271,
WZ2023_Pu_025_10min,0.5165699291408019,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.522060041087774,
FSO2013_Ratio M/L normalized Rep3___1,0.5115738260066504,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.5230619950244383,
CF2017_EOC 4,0.5225341764101806,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.522211448205269,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5205928697164445,
KS2014_Intensity C6,0.5159247715800317,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5164202002251739,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5200478701534007,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5178027934964502,
AH2018_SILAC_IT_2_C,0.5279936880790759,
CK2022_5 40-1,0.5181690304151878,
AH2018_LFQ_3_X,0.5258901524062556,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,0.5262189282013242,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.516952049362095,
SR2019_HCC1954_Biol_repl_3,0.5205279417812256,
CR2017_Ratio Replicate 2.2,0.5183506045192761,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5180812531390264,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5177355160164429,
PG2020_Intensity CT_B,0.516764609272611,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5271558878325142,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5216363895822764,
AH2018_LFQ_3_C,0.5267024767062545,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5270024748212642,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5189782678358278,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5208342452514756,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5230039179775479,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5299099344722641,
AH2018_TMTMS2_1_X,0.5327215151010884,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.5207841478392776,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.5216393039768364,
HH2022_Reporter intensity 4,0.5236924430147692,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5217187269725556,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.523976873112449,
HS2024_4_I_T3,0.5285131006971848,
AH2018_SILAC_1_X,0.5256774034853486,
PG2020_Intensity 10h_B,0.5169049469376736,
AH2018_TMTMS3_1_X,0.5226989211863211,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5154152521687183,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,0.5185884483222805,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.5247866326688759,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5230496597871986,
AS2011_Ratio H/L Normalized RNAi_2_1,,
